Association of A1C and Fasting Plasma Glucose Levels With Diabetic Retinopathy Prevalence in the U.S. Population
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the association of A1C levels and fasting plasma glucose (FPG) with diabetic retinopathy in the U.S. population and to compare the ability of the two glycemic measures to discriminate between people with and without retinopathy. RESEARCH DESIGN AND METHODS: This study included 1,066 individuals aged ≥40 years from the 2005–2006 National Health and Nutrition Examination Survey. A1C, FPG, and 45° color digital retinal images were assessed. Retinopathy was defined as a level ≥14 on the Early Treatment Diabetic Retinopathy Study severity scale. We used joinpoint regression to identify linear inflections of prevalence of retinopathy in the association between A1C and FPG. RESULTS: The overall prevalence of retinopathy was 11%, which is appreciably lower than the prevalence in people with diagnosed diabetes (36%). There was a sharp increase in retinopathy prevalence in those with A1C ≥5.5% or FPG ≥5.8 mmol/l. After excluding 144 people using hypoglycemic medication, the change points for the greatest increase in retinopathy prevalence were A1C 5.5% and FPG 7.0 mmol/l. The coefficients of variation were 15.6 for A1C and 28.8 for FPG. Based on the areas under the receiver operating characteristic curves, A1C was a stronger discriminator of retinopathy (0.71 [95% CI 0.66–0.76]) than FPG (0.65 [0.60 – 0.70], P for difference = 0.009). CONCLUSIONS: The steepest increase in retinopathy prevalence occurs among individuals with A1C ≥5.5% and FPG ≥5.8 mmol/l. A1C discriminates prevalence of retinopathy better than FPG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,130
Diabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, F. M. A., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 684 · cited 1×
“Moreover, retinopathy in the absence of diabetes (FPG 7 mmol/l) was more frequent among individuals of minority racial groups than whites (16), suggesting a higher likelihood of retinopathy not due to hyperglycemia among minority populations.”
BackgroundSelf-citationHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
McCane, D. R., Hanson, R. L., Charles, M. A., Jacobsson, L. T. H., Pettitt, D. D., Bennett, P. H., & Knowler, W. C. (1994) · BMJ · doi:10.1136/bmj.308.6940.1323 · Cited by 484 · cited 3×
“Second, we applied the cut points used in an analysis of the Pima Indians (2).”
BackgroundMethodResultInfluential
Cited by
Items 101–156 of 156
Longitudinal Glycemic Outcomes in Patients With Thyroid Eye Disease Treated With Teprotumumab
Ha, S. K., Lin, L. Y., Chiou, C. A., Wolkow, N., Lee, N. G., Yoon, M. K., & Freitag, S. K. (2025) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000003126 · Cited by 7
Sun, X., Du, T., Huo, R., & Xu, L. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0515-5 · Cited by 4
“In this regard, it is relevant to note the recent report of a better capacity of HbA1c versus FPG in discriminating prevalent retinopathy [30], and a higher predictive value of HbA1c versus FPG for future CV mortality and morbidity [31–33].”
BackgroundRESTREPO, N. A., Farber‐Eger, E. H., & Crawford, D. C. (2016) · PubMed Central · Cited by 6
Metabolic Syndrome Prevalence among Prediabetic and Normoglucotolerant Women
Mandob, D. E., & Sabine, P. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000705 · Cited by 5
“Prediabetes has no signs and symptoms, people with prediabetes have a greater risk of developing type 2 diabetes and/or associated complications [5-8].”
BackgroundKhandekar, R. B., Al-Hassan, A., Dhibi, H. A. A., Albahlal, A. A., & Al-Futais, M. (2015) · Oman Journal of Ophthalmology · doi:10.4103/0974-620x.169889 · Cited by 6
Diabetische Makulopathie und Retinopathie: Funktionelle und sozialmedizinische Bedeutung
Garweg, J. G., & Wenzel, A. (2010) · Der Ophthalmologe · doi:10.1007/s00347-010-2176-x · Cited by 6
“Zusätz-lich muss angenommen werden, dass der HbA1c-Grenzwert für die Entwicklung einer DR mit 5,5% deutlich niedriger liegt als bisher angenommen wurde und klinisch realisierbar erscheint [22].”
BackgroundPredictive Value of Screening Tests for Visually Significant Eye Disease
Kopplin, L. J., & Mansberger, S. L. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.05.033 · Cited by 5
“Our analysis identified a history of diabetes, abnormal blood sugar or hemoglobin A1C, and abnormal nonmydriatic photographs as associated with diabetic retinopathy, which reemphasizes the usefulness of these screening modalities in monitoring for diabetic eye disease.(31,32) Sensitivity and specificity estimates for…”
Khatana, S. A. M., Taveira, T. H., Dooley, A. G., & Wu, W. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00296.x · Cited by 8
Rivers, K. L., & Hanna-Mahase, C. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000511 · Cited by 5
“This information may also indicate the need for further clinical evaluations to determine whether elevated HbA1c levels are associated with complications such as diabetic retinopathy or nephropathy [34,35], or if this is simply a normal genetic quality of this particular group.”
BackgroundAn Overview of Diabetes and Ocular Health
Nakao, S., & Hata, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00013-9 · Cited by 4
Saunajoki, A., AUVINEN, J. P., Saarela, V. O., Uusitalo, J., Leiviskä, I. L., Keinanen-Kiukaanniemi, S. M., Liinamaa, J., & Timonen, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240983 · Cited by 4
Tran, E., Gregori, N. Z., Rachitskaya, A., Nandan, A., Pershing, S., & Goldberg, J. L. (2025) · Clinical ophthalmology · doi:10.2147/opth.s487047 · Cited by 3
Tatti, P., Mauro, P. D., Masselli, L., Longobardi, A., & Barber, A. (2010) · Clinical ophthalmology · doi:10.2147/opth.s10273 · Cited by 4
La hemoglobina glucosilada como criterio diagnóstico de diabetes mellitus
Rius, F. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.01.010 · Cited by 4
The Chronic Injury Glucose Error Grid
Krouwer, J. S., & Cembrowski, G. S. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814554415 · Cited by 3
“5% which corresponds to an average glucose level of 111 mg/dL.(5) Within the A zone of a glucose meter error grid, diabetic retinopathy can be a serious problem which implies that the current glucose meter error grid is not appropriate as an acceptance criterion for chronic injury.”
BackgroundGenezing van diabetes mellitus type 2?
Huls, M., van Dijk, M., & Boesten, M. (2013) · Huisarts en Wetenschap · doi:10.1007/s12445-013-0040-3 · Cited by 3
Can We Become Victims of Our Own Success?
Buse, J. B. (2009) · Diabetes Care · doi:10.2337/dc09-1653 · Cited by 3
“(3) present another masterful analysis of the NHANES dataset.”
BackgroundScreening for and Prevention of Diabetes in India: Need for Simple and Innovative Strategies
Gupta, R., & Misra, A. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0178 · Cited by 3
“6 Furthermore, it is affected less in acute situations; day-to-day and within-person variations of HbA1c are < 2%, whereas those for FPG are 12–15%.”
Alhalwani, A. Y., Khan, M. A., Bahadur, R. Y., Almalki, H. A., & Sannan, N. (2023) · The Open Ophthalmology Journal · doi:10.2174/0118743641277168231201102545 · Cited by 3
Validation of HbA1c of 6.5% for Diagnosing Diabetes Mellitus via the Use of Taxometric Analysis
Ingram, D. G., & Bachrach, B. E. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.10.002 · Cited by 2
Diagnosing Diabetes with A1C: Implications and considerations for measurement and surrogate markers
Hill, A. N., & Appel, S. J. (2010) · The Nurse Practitioner · doi:10.1097/01.npr.0000388206.16357.02 · Cited by 3
Perreault, L. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_2 · Cited by 1
The Role of Hemoglobin A1C in Diabetes Screening and Diabetic Retinopathy
Villacreses, M. M. C., Karnchanasorn, R., Ou, H., Samoa, R. A., Chuang, L., & Chiu, K. C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214947 · Cited by 1
“Although the current A1C cutoff was selected based on linear inflections of prevalence of diabetic retinopathy in three population studies [7,29,30] and supported by some studies [31,32], a lower A1C cutoff has been suggested by other studies for diabetic retinopathy [20,33,34].”
MethodArtificial Intelligence and Diabetes Prevention
Perreault, L. (2025) · JAMA · doi:10.1001/jama.2025.20099 · Cited by 1
Genezing van diabetes mellitus type 2?
Reenders, K., & Verhoeven, S. (2013) · Huisarts en Wetenschap · doi:10.1007/s12445-013-0193-0 · Cited by 1
Escobedo, J., Velasco, X., Pellegrini, F., & Copetti, M. (2013) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-2-19 · Cited by 1
“For example, the prevalence of diabetic retinopathy progressively increases with rising glucose or glucosilated hemoglobin values, even before the cutoff points used to diagnose diabetes [6,7], which in turn implies that some subjects classified as pre-diabetic in fact already have the disease.”
BackgroundGlycated Hemoglobin as a Marker of Dyslipidemia in Type II Diabetic Patients
Arora, R. (2016) · International Journal of Medical and Dental Sciences · doi:10.19056/ijmdsjssmes/2016/v5i2/100600 · Cited by 2
Mv, L. (2017) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2017.04.00103 · Cited by 1
Demissie, G. D., Birungi, J., Haregu, T., Sathish, T., & Oldenburg, B. F. (2024) · JMIR Research Protocols · doi:10.2196/53517 · Cited by 1
Lu, Y., Duong, T. T., Miao, Z., Thieu, T., Lamichhane, J., Ahmed, A., & Delen, D. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae140 · Cited by 1
Mahmoud, H. E. M., Alsenbesy, M., Sayed, G. O. F., Ali, A. E. M., & Sabra, A. M. (2021) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-021-00063-y · Cited by 1
Direção veicular em indivíduos com retinopatia diabética: revisão e reflexão sobre as normas atuais
Botassio, A. D. A., Yamasato, J. M., & de Medeiros, C. M. (2015) · Saúde Ética & Justiça · doi:10.11606/issn.2317-2770.v20i1p21-28
Bowden, J. N. (2011) · Montana State University ScholarWorks (Montana State University)
Acute Versus Chronic Injury in Error Grids
Krouwer, J. S., & Cembrowski, G. S. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814543662
“5% are associated with diabetic retinopathy.(2) Yet an A1c level of 5.”
BackgroundKumar, A., Motwani, R., Ghauri, M. I., Begum, N., Saeed, F., Salahuddin, S., & Shaikh, I. (2013)
Tako, M., Shimabukuro, J., Jiang, W. J., Yamada, M., Ishida, H., & Kiso, M. (2013)
Balancing Complications and Metabolic Benefit
Chousleb, E., Chousleb, S., & Zundel, N. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3220-7_16
Kan diabetes mellitus type 2 genezen?
Huls, M., van Dijk, M., & Boesten, M. (2015) · TvPO · doi:10.1007/s12503-015-0081-0
Treatments for Type 2 Diabetes; a Focus on DPP4 Inhibitors
TOMKIN, G. H. (2014) · Pharmaceutical Regulatory Affairs Open Access · doi:10.4172/2167-7689.1000114
“The first step depends on getting the patient at the very beginning of their path, that is in the pre-diabetes stage, but even then they may have already suffered from macrovascular and/or microvascular damage [4-7].”
BackgroundWie kriegt man das Gefäßrisiko in den Griff?
Stirban, O. A., & Tschöpe, D. (2015) · Info Diabetologie · doi:10.1007/s15034-015-0499-z
“Verbesserung der Stoffwechseleinstellung Die Grenzwerte für die Diagnose eines T2D basieren auf Daten epidemiologischer Studien, in denen es Korrelationen zwischen der Nüchtern-Plasmaglukose, dem 2-Stunden-Wert im oralen Glukosetoleranztest und dem HbA1c einerseits mit der Inzidenz einer Retinopathie andererseits gab…”
BackgroundVenkataraman, K., Kao, S. L., Thai, A. C., Salim, A., Heng, D., & Khoo, E. Y. H. (2012)
Zhang, X. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/99f4-gf26
Self-citationUtilizing Temporal Information in The EHR for Developing a Novel Continuous Prediction Model
Hsieh, K. (2019) · Digital Commons-TMC (Texas Medical Center)
Diabetische Makulopathie und Retinopathie: Funktionelle und sozialmedizinische Bedeutung
Garweg, J. G., & Wenzel, A. (2010) · Bern Open Repository and Information System (University of Bern)
Current literature in diabetes
John Wiley & Sons, L. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1019 · Cited by 1
Cheng, C. H. E. N., Qiu, S., Du, Z., Guo, H., Wang, B., Sun, Z., & Wang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1406302/v1
Commendatore, V., Faingold, C., Fenili, C., Frechtel, G. D., González, C. D., Llanos, I., Lucarelli, C., Maselli, M. D. C., Mazza, C., Puchulu, F., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v57i1.676 · Cited by 8
Tahir, A. R. M., Haw, V. J., Zaid, W. S. W., Nizaruddin, M. A., & Ludin, A. F. M. (2023) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2023.23428
Role of newer anti-diabetes drugs in prediabetes: A systematic review
Singh, A. K., & Singh, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00037-2
Arguinchona, L. M., Caldwell, A. S., Gill, Z. S., Gange, W. S., Le, C. B., Mehta, N. B., Marin, A. I., & Manoharan, N. (2024) · Retinal Cases & Brief Reports · doi:10.1097/icb.0000000000001591
Moummou, H., Karoumi, J., Tilaoui, M., Sabir, E., Meftah, I., Achoch, M., Chatoui, H., Hiba, O. E., & Bahi, L. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004618
Nandula, S. A., Casola, A. R., Rao, A. D., Turella, J., Quach, H., Jeffrey, H., Zhang, Y., & Ulas, M. (2026) · Research Square · doi:10.21203/rs.3.rs-11106749/v1
Tolkacheva, V. V., Вадимовна, В. С., & Kobalava, Z. D. (2012) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2012-18-2-83-95 · Cited by 1
Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a multi-ethnic population
Mostafa, S. A. (2014) · Figshare
Laboratory Testing, Electrocardiography and Imaging
Taylor, R. B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7874-5_7
Metadata
- Authors
- Cheng, Y. J., Gregg, E. W., Geiss, L. S., Imperatore, G., Williams, D. E., Zhang, X., Albright, A. L., Cowie, C. C., Klein, R., & Saaddine, J. B.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Cheng, Yiling J.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2027-2032
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768189
- OpenAlex
- W2163807150
- Cited by
- 157
- References
- 29
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 7 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 12 · 2015: 20 · 2014: 19 · 2013: 10 · 2012: 15
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, HbA1c, fasting blood glucose, glycemic control, retinopathy prevalence, retinopathy screening, diagnostic discrimination, color fundus photography, undiagnosed diabetes, NHANES
- MeSH terms
- Blood Glucose, Diabetic Angiopathies, Diabetic Retinopathy, Ethnicity, Fasting, Female, Glycated Hemoglobin, Humans, Hypertension, Male, Middle Aged, Nutrition Surveys, Sensitivity and Specificity, United States, Prevalence, Patient Selection, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

